Comparison of Peripheral Blood Stem Cell Transplantation With Bone Marrow Transplantation for the Treatment of Serious Hematological Malignancies
A Phase III Randomized, Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell With Marrow Transplantation From HLA Compatible Unrelated Donors.
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago
Listed as NCT00275678, this PHASE3 trial focuses on Blood Stem Cell Transplant and remains completed. Sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE3
-
Jun 2018 — Nov 2019 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Nov 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ann & Robert H Lurie Children's Hospital of Chicago
- Duke University
- Mayo Clinic
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institutes of Health (NIH)
- National Marrow Donor Program
- University of Florida
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .